Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2008
09/03/2008CN101255161A Method for synthesizing 3,9-diaza-2,4-dioxo-spiro[5.5] undecane template compounds
09/03/2008CN101255160A Method for synthesizing 3,9-diaza-2-oxo-spiro[5.5] undecane template compounds
09/03/2008CN101255159A Method for synthesizing 3,9-diaza spiro[5.5] undecane template compounds
09/03/2008CN101254158A Kation azo-dyes with julolidine unit, dyeing combination containing coloring agent and colored method
09/03/2008CN100415746C Aminopyridine-derivatives as inductible NO-synthase inhibitors
09/03/2008CN100415745C Imidazopyridine-derivatives as inductible NO-synthase inhibitors
09/03/2008CN100415744C 2-arylamino-pyrimidines for the treatment of GSK3-related disorders
09/03/2008CN100415743C Derivatives of pyrimido [6.1-a] isoquinolin-4-one
09/03/2008CN100415718C CASPASE inhibitors and use thereof
09/03/2008CN100415716C 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative
09/02/2008US7420059 HMG-CoA reductase inhibitors and method
09/02/2008US7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
09/02/2008US7419985 reuptake of norephinephrine, dopamine, and serotonin inhibitor; furo-, pyrrolo-, and thienyl-tetrahydroisoquinolines, e.g. 2 methyl 4 phenyl 1,2,3,4,8,9 hexahydro furo[2,3 h]isoquinoline; antidepressant, anxiolytic agent; neurological and psychological disorders
09/02/2008US7419981 Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
09/02/2008US7419978 Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
09/02/2008US7419977 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2- alpha ]quinoline-2-carbonyl)morpholine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives
09/02/2008US7419975 Organic compounds
09/02/2008US7419969 N-((hetero)arylalkyl)pyrimidonecarboxamides in which the ring is fused to a C4-7(hetero)cycloalkyl ring, which in turn has a spiro ring attached: e.g., N-[(4-fluorophenyl)methyl]-7',8'-dihydro-3'-hydroxy-8'-methyl-4'-oxo-spiro[cyclopentane-1,9'(6'H)-[4H]pyrazino[1,2-a]pyrimidine]-2'-carboxamide
09/02/2008CA2386813C Bicyclic imidazo-3-yl amine derivatives substituted on the 6-membered ring
08/2008
08/28/2008WO2008103899A1 Preparation and utility of non-nucleoside reverse transcriptase inhibitors
08/28/2008WO2008103637A1 Compounds for the treatment of hepatitis c
08/28/2008WO2008103470A2 Oncogenic-ras-signal dependent lethal compounds
08/28/2008WO2008103277A2 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
08/28/2008WO2008103126A1 Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma
08/28/2008WO2008102749A1 Heterocyclic compound
08/28/2008WO2008101824A1 Imidazo[1',5':1,6] pyrido[3,4-b]indoles derivatives and therapeutical use thereof
08/28/2008WO2008101682A2 Iminipyridine derivatives and their uses as microbiocides
08/28/2008WO2008101660A1 Spirocyclic cyclohexane derivatives
08/28/2008WO2008101659A1 Spirocyclic cyclohexane derivatives
08/28/2008WO2008101587A1 4-(pyrrolopyridinyl)pyrimidin-2-ylamine derivatives
08/28/2008WO2008071766A3 Spiro-indene substituted imidazonaphythyridine and pyranoimidazopyridine derivatives as inhibitors of gastric acid secretion
08/28/2008WO2008070041A3 Inhibitors of akt activity
08/28/2008WO2008059521A3 Novel process for the preparation of moxifloxacin hydrochloride and a novel polymorph of moxifloxacin
08/28/2008US20080207907 Process For Pd-Catalysed C-N Coupling In Specific Solvent Systems
08/28/2008US20080207896 Cyclization; in crystal or amorphous formk
08/28/2008US20080207708 Analgesics; antiinflammatory agents; bone disorders; neurodegenerative diseases
08/28/2008US20080207684 Kinase inhibitors and methods for using the same
08/28/2008US20080207683 Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s
08/28/2008US20080207682 Phenylurea Derivatives As Inhibitors Of Tyrosine Kinases For The Treatment Of Tumour Diseases
08/28/2008US20080207680 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
08/28/2008US20080207677 Napthyridine Compounds As Rock Inhibitors
08/28/2008US20080207675 Aqueous Gel Formulations Containing 1-(2-Methylpropyl)-1H-Imidazo[4,5-C][1,5]Naphthyridin-4-Amine
08/28/2008US20080207666 Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
08/28/2008US20080207651 Asthma therapy; antiallergens; antiinflammatory agents
08/28/2008US20080207650 Chemical Compounds 636
08/28/2008US20080207647 Pyrazole Derivatives Having Tyrosine Kinase Activity
08/28/2008US20080207634 Chemical Compounds
08/28/2008US20080206312 Therapeutic Morpholino-Substituted Compounds
08/28/2008US20080206258 Novel Tetrahydropyridothiophenes
08/28/2008US20080206163 INHIBITORS OF PHOSPHODIESTERASE (PDE) ISOENZYMES; USEFUL FOR TREATMENT OF RESPIRATORY DISORDERS SUCH AS ASTHMA; chronic obstructive pulmonary disease (COPD); 9,10-Dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one
08/28/2008DE102007009494A1 New 1,6-naphthyridine or 8-azaquinazoline derivatives useful for treating aldosteronism, hypertension, cardiac insufficiency, myocardial infarct sequelae, liver cirrhosis, renal insufficiency and stroke
08/28/2008DE102007009319A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives
08/28/2008DE102007009264A1 New 9-alkyl-beta-carboline compounds are dopamine receptor stimulators useful to treat and/or prevent movement disorder, Alzheimer's disease, Parkinson's disease and Wilson's diseases, and as additives for accelerating cell growth
08/28/2008DE102007008419A1 4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate 4- (pyrrolopyridinyl) -pyrimidinyl-2-amine derivatives
08/28/2008CA2679173A1 Spirocyclic cyclohexane derivatives
08/28/2008CA2679166A1 Spirocyclic cyclohexane derivatives
08/28/2008CA2678691A1 4-(pyrrolopyridinyl)pyrimidin-2-ylamine derivatives
08/28/2008CA2677877A1 New indole derivative compounds and pharmaceutical compositions containing the same
08/28/2008CA2676173A1 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
08/27/2008EP1961745A1 Bicyclic heterocyclic compound
08/27/2008EP1961416A1 Medical use of inhibitors of glutaminyl and glutamate cyclases
08/27/2008EP1960401A1 Tricyclic amide derivatives useful for treating obesity
08/27/2008EP1960400A1 Pyrazoloisoquinoline derivatives
08/27/2008EP1960399A1 Pyrrolopyridines as kinase inhibitors
08/27/2008EP1960398A1 Aryl acetic acid and ester derivatives and their uses as antiinflammatory
08/27/2008EP1960382A1 Heterocyclic compounds as tyrosine kinase modulators
08/27/2008EP1960368A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
08/27/2008EP1960356A2 Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors
08/27/2008EP1960355A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
08/27/2008EP1959959A2 Morpholine carboxamide prokineticin receptor antagonists
08/27/2008EP1716145B1 Dihydrotetrabenazines and pharmaceutical compositions containing them
08/27/2008EP1660484B1 Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists
08/27/2008EP1622569A4 Aza spiro alkane derivatives as inhibitors of metallproteases
08/27/2008EP1467997B8 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
08/27/2008EP1349858B1 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
08/27/2008CN101253173A Hydroxy substituted 1H-imidazopyridines and methods
08/27/2008CN101253164A Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists
08/27/2008CN101252935A Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use
08/27/2008CN101250188A Technique for preparing willow leaf tabersonine
08/27/2008CN101250187A Fatty amido substituted methylindole quinoline derivatives as well as preparation method and use thereof as anti-tumour drugs
08/27/2008CN101250155A Method for preparing chiral alpha-alkenyl(or alkynyl group)-alpha'-alkyl piperidine as well as N-Cbz derivatives and use thereof
08/27/2008CN100413866C Riboflavin derivative and its preparation method and uses
08/27/2008CN100413865C Diaza-spiropiperidine derivatives
08/27/2008CN100413864C [1,7]naphthyridines as PDE4 inhibitors
08/27/2008CN100413863C Novel 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same
08/26/2008US7417152 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring
08/26/2008US7417145 Process for total synthesis of ecteinascidins and intermediates therefor
08/26/2008US7417054 Naphthyridine compounds
08/26/2008US7417053 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
08/26/2008US7417052 Phenylene derivative having tetrazole ring or thiazolidinedione ring
08/26/2008US7417046 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma
08/26/2008US7417041 Imidazopyrimidines as transforming growth factor (TGF) inhibitors
08/26/2008CA2432129C Pyrazole compounds useful as protein kinase inhibitors
08/26/2008CA2397961C Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors
08/26/2008CA2274825C Substituted nitrogen containing heterocycles as inhibitors of p38 protein kinase
08/21/2008WO2008101247A2 6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity
08/21/2008WO2008100715A1 Aza-isoindolones and their use as metabotropic glutamate receptor potentiators - 613
08/21/2008WO2008100635A1 1- [3- (monocyclic amino) propyl] - 4, 5, 6, 7-tetrahydro-1h-pyrazolo [4, 3-c] -pyridines as modulators of cathepsin s
08/21/2008WO2008100622A2 Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s
08/21/2008WO2008100620A2 Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
1 ... 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 ... 646